EARLY DETECTION. HIGH SURVIVAL. ACCESSIBLE TO EVERYONE.
Novel Early
Cancer Screening
EARLY DETECTION. HIGH SURVIVAL. ACCESSIBLE TO EVERYONE.
Novel Early
Cancer Screening
Revolutionizing The Global
Fight Against Cancer
Acuamark Diagnostics develops technology which allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable.
Backed by a highly experienced team of scientific and business professionals, it is our mission to contribute to the global battle against cancer by detecting and attacking cancer through high-precision, early detection.
Highly Accurate Technology
Revolutionizing the global fight against cancer by developing highly accurate cancer screening blood tests for early detection
Innovative, Differentiated Technology for
Early Cancer Detection
Our Eagle i5 assays detect cancer markers in multiple dimensions, including mutation, methylation, exosomal miRNA, lncRNA and mRNA, translocations and splice variants.
From there, we are able to quantitatively determine the cancer marker load in a blood sample.
Highly Accurate Technology
Revolutionizing the global fight against cancer by developing highly accurate cancer screening blood tests for early detection
Innovative, Differentiated Technology for
Early Cancer Detection
Our Eagle i5 assays detect cancer markers in multiple dimensions, including mutation, methylation, exosomal miRNA, lncRNA and mRNA, translocations and splice variants.
From there, we are able to quantitatively determine the cancer marker load in a blood sample.
Latest News & Posts
Latest articles and news regarding the developing technology. Stay updated with the recent posts.
Acuamark Diagnostics Welcomes Dr. Kennedy to the Board of Directors
Acuamark Diagnostics Secures $11.3 Million Series A Funding to Advance Innovative Assays for Improved, Cost-Effective Early-Cancer Detection
